Use of microaxial flow pumps in adolescentsCentral MessagePerspective

Objectives: The Impella 5.5 has been successfully used in the adult population; however, safety and efficacy data in patients aged less than 18 years are limited. Methods: Six pediatric patients, aged 13 to 16 years and weighing 45 to 113 kg, underwent axillary artery graft placement and attempted p...

Celý popis

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Lauren E. Parker, BS, Douglas M. Overbey, MD, Lillian Kang, MD, Cathlyn K. Medina, BA, Leonie M. Kurzlechner, BS, Ziv Beckerman, MD, Nicholas D. Andersen, MD, Jacob N. Schroder, MD, Joseph Turek, MD, PhD, MBA
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-10-01
Edice:	JTCVS Techniques
Témata:	cardiomyopathy Impella 5.5 LVAD pediatric heart failure
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666250723002699
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Use of microaxial flow pumps in adolescentsCentral MessagePerspective

Podobné jednotky